Viking Therapeutics

Viking Therapeutics

VKTX

Reported
Wednesday, October 23

Q3 2024 Earnings

(USD)ExpectedReportedSurprise $Surprise %
EPS-0.25-0.220.0312.00%
Revenue-0.00--
WhatIF - Earnings
EPS Beat Expectations by $0.03
emptyImageAlt
Viking Therapeutics (VKTX:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything